ATOM
The AI engine Fit Assessment
BetaATOM leverages machine learning and data-driven modeling to enhance drug discovery, focusing on developing new therapeutics and optimizing the drug design process.
Blurb
ATOM is a public-private partnership with the mission of transforming drug discovery by accelerating.
HQ Location
San Francisco (United States)
Founded
2017
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission of transforming drug discovery by accelerating the development of more effective therapies for patients.